ATMA CENA offers three psychedelic-assisted therapy training pathways: Integrative (CAD $3,870), Clinical (CAD $5,400), and Prescriber (CAD $4,320). Choosing the right one is not a matter of preference — it is a matter of credential, scope of practice, and what your provincial regulatory college will recognize. This guide maps each pathway to the credentials it serves, with the regulatory reasoning behind each fit.

Key takeaways

Prescriber Pathway is for physicians and nurse practitioners who hold prescribing authority and will submit Health Canada SAP applications or prescribe ketamine.

Clinical Pathway is for licensed therapists (registered psychologists, psychotherapists, clinical counsellors, social workers, psychiatric nurses) whose scope includes psychotherapy or psychosocial intervention.

Integrative Pathway is for unregulated wellness practitioners (yoga therapists, somatic practitioners, breathwork facilitators, death doulas, integration coaches) who provide preparation and integration support outside of SAP sessions.

Pathway choice is determined by your regulatory credential — not personal preference. A wellness practitioner cannot legally take the Clinical Pathway role; a physician taking only the Integrative Pathway will not have prescribed-authority modules.

All three pathways share the Foundations course as a common entry point.

Why pathway choice matters before you register

Canadian psychedelic-assisted therapy operates under three governing layers: federal (Health Canada SAP and the Controlled Drugs and Substances Act), provincial (scope of practice for each regulated profession), and your regulatory college's standards of practice. A training program completed in the wrong pathway does not change what your license authorizes — it just costs you tuition.

The decisive question is not "which pathway interests me?" It is: which restricted activities does my registration authorize, and which pathway delivers the training that maps to those activities?

The three pathways at a glance

	Integrative	Clinical	Prescriber
Total cost (CAD, bundled)	$3,870	$5,400	$4,320
Total CE/CME hours	53	69	54
Constituent courses	Foundations + Advanced Safety & Support	Foundations + Applied Clinical Practice + Supervised Lab	Foundations + Prescribing & Oversight
Submit Health Canada SAP?	No	No	Yes
Prescribe ketamine / psychedelics?	No	No	Yes
Therapist of record in PAP team?	No	Yes (under prescriber oversight)	Possible (with training)
Provide preparation / integration?	Yes (outside SAP context)	Yes	Yes
CME / CE accreditation	CPA-recognized CE	CPA-recognized CE	CPA-recognized + CFPC Mainpro+
Best fit credential	Unregulated wellness practitioner	Licensed mental health professional	Physician (MD) or NP

Compare the full curriculum, modules, and cohort dates.

Mapping your credential to the right pathway

The credential-to-pathway map below covers the full range of Canadian regulated and unregulated practitioner types. Each row identifies the appropriate pathway and the regulatory reasoning.

Credential	Province scope	Pathway	Why
Physician (MD) — psychiatrist	All provinces	Prescriber	Holds prescribing authority; only practitioner type that can act as sole prescriber for psychedelics in Alberta under MHSP.
Physician (MD) — family / GP	All provinces	Prescriber	Holds prescribing authority; can submit SAP applications. AB requires psychiatrist co-sign at PAPT-licensed facilities.
Nurse Practitioner	All provinces	Prescriber	Holds prescribing authority; SAP-eligible. AB adds psychiatrist co-sign requirement at licensed facilities.
Registered Psychologist (doctoral)	All provinces	Clinical	Highest non-prescribing scope; psychological assessment + psychotherapy authority; CAP June 2025 explicitly authorizes participation.
Psychological Associate (master's, autonomous)	ON, MB	Clinical	Independent psychotherapy scope; must hold autonomous registration and work under prescriber oversight.
Registered Psychotherapist (CRPO)	Ontario	Clinical	Holds controlled-act certificate for psychotherapy; CRPO interim guidance authorizes PAP within SAP teams.
OPQ Psychotherapist Permit holder	Quebec	Clinical	Reserved-act authorization in Quebec; eligible for SAP team participation.
Registered Clinical Counsellor (BCACC)	BC	Clinical	BCACC October 2024 guidance authorizes participation in SAP teams under prescriber oversight.
Canadian Certified Counsellor (CCPA only, no provincial regulated credential)	All provinces	Integrative	Voluntary association credential; not a controlled-act authorization in most provinces.
Registered Social Worker (clinical)	All provinces	Clinical	Authorized to perform psychosocial intervention; AB MHSP explicitly lists ACSW.
Registered Psychiatric Nurse (RPN)	AB, BC, SK, MB	Clinical	AB MHSP explicitly authorizes CRPNA; can also administer prescribed dose under physician order.
Registered Nurse (general)	All provinces	Clinical (administration role)	Can administer prescribed psychedelics under physician order; therapist-of-record role limited.
Occupational Therapist (with psychosocial intervention authority)	All provinces (ACOT in AB explicitly authorized)	Clinical	AB MHSP lists ACOT among 6 authorized colleges.
Yoga therapist, somatic practitioner, breathwork facilitator	All provinces	Integrative	Unregulated; cannot legally provide PAP within SAP teams. Integration support outside SAP context only.
Pastoral counsellor, death doula, integration coach	All provinces	Integrative	Unregulated; same scope limits as wellness practitioners.
Registered Massage Therapist	BC, AB, ON, NB	Integrative	Regulated but scope limited to manual soft-tissue therapy; PAP outside scope.

The Clinical Pathway — for licensed therapists ready to deliver

The Clinical Pathway (CAD $5,400; 69 CE hours; bundled at 10% discount) is the pathway most regulated mental health professionals will select. It includes Foundations, Applied Clinical Practice in Psychedelic Therapy, and the Supervised Learning Lab.

Who it serves: Registered Psychologists (CAP, CHCPBC, CPBAO, PAM, OPQ), Registered Psychotherapists (CRPO Ontario), OPQ Psychotherapist Permit holders (Quebec), Registered Clinical Counsellors (BCACC), Registered Social Workers with clinical authorization (ACSW Alberta, BCCSW BC, OCSWSSW Ontario, OTSTCFQ Quebec with OPQ permit), Registered Psychiatric Nurses (CRPNA Alberta), Occupational Therapists with psychosocial intervention authority.

What it enables: Delivery of preparation, dosing-session therapeutic support, and integration psychotherapy within a SAP-authorized clinical team or research trial. Practitioners do not prescribe or administer the controlled substance — that role belongs to the prescribing physician or NP. Clinical Pathway graduates serve as therapist of record under prescriber oversight.

The evidence base: The therapeutic alliance is the most-replicated outcome predictor across psychedelic-assisted trials. In a 2024 randomized waiting-list trial in MDD, "stronger total alliance one week after the final psilocybin session predicted depression scores at 4 weeks, 3 months, 6 months, and 12 months post-intervention" (Levin et al., 2024). The MAPP1 Phase 3 MDMA trial established the manualized clinical delivery model — three preparatory, three medicine, and nine integration sessions (Mitchell et al., 2021) — that the Clinical Pathway trains practitioners to implement. Phelps's 2017 framework defines six core competencies (empathetic abiding presence, trust enhancement, spiritual intelligence, pharmacological knowledge, ethical integrity, complementary technique proficiency) that the Clinical Pathway curriculum operationalizes (Phelps, 2017).

Explore the Clinical Pathway curriculum, modules, and cohort dates.

The Prescriber Pathway — for physicians and nurse practitioners

The Prescriber Pathway (CAD $4,320; 54 CE hours; bundled at 10% discount) is the only clinical pathway that includes prescriber-specific training. It includes Foundations and Prescribing & Oversight in Psychedelic-Assisted Therapy.

Who it serves: Physicians (MDs) — psychiatrists and family physicians with appropriate clinical foundation; Nurse Practitioners with full prescribing authority. Health Canada's Special Access Program prescriber-eligibility rule requires the practitioner to be "licensed to prescribe drugs in the province or territory where they practice" (Health Canada SAP Notice).

What it enables: Submitting SAP applications for psilocybin or MDMA on behalf of patients, prescribing ketamine off-label for psychiatric indications, providing medical oversight during dosing sessions, and (where Alberta MHSP applies) operating within a CPSA-accredited PAPT facility.

Alberta-specific rule: Under Alberta's Mental Health Services Protection Regulation, only a psychiatrist — or a physician in consultation with a psychiatrist — may prescribe a designated psychedelic drug at a CPSA-accredited facility. A general practice physician cannot act as sole prescriber in Alberta. CPSA released formal ketamine prescribing guidance in March 2026.

The evidence base: The Canadian Network for Mood and Anxiety Treatments (CANMAT) recommends single-dose IV racemic ketamine as a third-line treatment for adults with treatment-resistant MDD, with the explicit standard that "clinicians administering ketamine should have medical training and qualifications to manage behavioral and cardiovascular adverse events" (Swainson et al., 2021). The Edmonton community ketamine program demonstrates real-world Canadian implementation at scale (Chrenek et al., 2024).

The Prescriber Pathway carries CFPC Mainpro+ recognition. Explore the Prescriber Pathway.

The Integrative Pathway — for allied and wellness professionals

The Integrative Pathway (CAD $3,870; 53 CE hours; bundled at 10% discount) is for practitioners who do not hold a clinical credential authorizing the controlled act of psychotherapy or psychosocial intervention. It includes Foundations and Advanced Safety & Support Practices in PAT.

Who it serves: Yoga therapists, somatic practitioners, breathwork facilitators, pastoral counsellors, death doulas, integration coaches, registered massage therapists, and CCPA-CCC counsellors who do not hold a provincial regulated credential.

Hard scope limit: Integrative Pathway graduates cannot apply to Health Canada SAP, prescribe psychedelics, serve as therapist of record in a PAP team, or be present at a dosing session in any role that involves handling the controlled substance. Their role is integration support: helping clients process experiences they have already had through a legally authorized PAP session that the Integrative practitioner had no role in facilitating, plus psychoeducation and somatic-wellness preparation.

Legal warning: Practitioners in any unregulated role who facilitate access to psilocybin or MDMA — even by connecting clients to underground facilitators — may face CDSA criminal liability regardless of therapeutic intent.

The evidence base: The Psychedelic Harm Reduction and Integration (PHRI) model defines the role: "PHRI represents a shift away from assessment limited to untoward outcomes of psychedelic use…toward a stance of compassionate, destigmatizing acceptance of patients' choices" (Gorman et al., 2021). A 2024 validation study of the Protective Strategies for Psychedelics Scale provides a measurable instrument that integration practitioners can use to assess and reinforce client preparation (Mian et al., 2024).

The Integrative Pathway is also appropriate for clinical practitioners who want foundational literacy without intending to deliver SAP-context PAP — for example, an RP who refers PAP clients out and provides only post-experience integration.

Explore the Integrative Pathway.

Decision blocks: "What if I am a [credential] in [province]?"

"I am a Registered Psychotherapist in Ontario"

Pathway: Clinical. CRPO interim guidance authorizes PAP participation within SAP or clinical-trial contexts. You cannot prescribe, advise on medication, or possess controlled substances. You will need a prescribing physician or NP partner before accepting PAP referrals.

"I am a psychiatrist in Alberta"

Pathway: Prescriber. Under Alberta's MHSP, only psychiatrists (or physicians with psychiatrist consultation) can prescribe psychedelics at CPSA-accredited facilities. Pair with a regulated therapist (CAP psychologist, CRPNA, ACSW) for session delivery; you may also deliver the therapy component if separately trained.

"I am a family physician in British Columbia"

Pathway: Prescriber. No psychiatrist co-sign required (unlike AB). You can submit SAP requests for psilocybin or MDMA and prescribe ketamine off-label. Partner with a licensed therapist for the therapeutic component.

"I am a Registered Clinical Counsellor in BC"

Pathway: Clinical (within SAP team) or Integrative (solo integration practice only). BCACC October 2024 guidance authorizes participation in SAP teams under prescriber oversight. Without a prescriber partner you can only provide integration support to clients who underwent PAP elsewhere.

"I am a Registered Social Worker in Quebec"

Pathway: Clinical (with OPQ psychotherapist permit) or Integrative (without permit). Quebec's reserved-act framework requires the OPQ psychotherapist permit for non-psychologist, non-physician practitioners delivering psychotherapy.

"I am a Registered Psychiatric Nurse in Alberta"

Pathway: Clinical. CRPNA is one of six authorized colleges under Alberta MHSP. You cannot prescribe, but you can administer the prescribed dose during sessions under physician order — a role open to RPNs that most non-nursing therapists cannot fill.

"I am a death doula or yoga therapist in Ontario"

Pathway: Integrative. You cannot apply to SAP, prescribe, or be present at dosing sessions as a facilitator. You can provide integration support and psychoeducation outside SAP context. ATMA CENA Essentials/Integrative gives you foundational literacy for legitimate work in this scope.

Edge cases

Dual-credentialed practitioners (e.g., RCC + MSW): Apply the more permissive of the two college guidance documents, but comply with whichever standard is more restrictive on any given issue. You are governed by both colleges simultaneously.

Students in regulated programs: Provisional or supervised-practice registrants cannot serve as therapist of record. They may observe and learn under direct supervision of a fully registered practitioner. Begin with Foundations or Integrative for personal education; complete Clinical Pathway upon full registration.

Retired or inactive registrants: Cannot submit SAP applications. Cannot serve as therapist of record. May complete any pathway for personal education, consulting, research, or advocacy without regulatory implications.

Out-of-province practice: Registration follows province of patient, not province of registration. Telehealth across provincial boundaries requires confirmation from your college on inter-jurisdictional practice rules.

ROI and career framing by pathway

A trained Clinical Pathway practitioner billing 8–12 KAT psychotherapy sessions per month at CAD $200–$300/hour generates CAD $1,600–$3,600/month — covering pathway tuition in 2–4 months of post-training practice. A Prescriber Pathway physician adding KAT to an existing practice can offset the CAD $4,320 tuition within 1–2 months given current Canadian session-fee structures. The Integrative Pathway is harder to ROI directly because integration coaching rates vary widely (CAD $75–$200/hour) and demand is less consolidated; clinicians who already have an existing wellness practice will see the fastest fee uplift.

The coordinated care model connects Clinical Pathway graduates to clinic-network referrals and supervised practice without requiring you to leave private practice or build a new facility — one mechanism for accelerating ROI on training spend.

What happens after you complete your pathway

Pathway completion is the gateway, not the destination. Three post-training tracks:

Independent practice within an existing clinic or hospital — most psychiatrists, psychologists, and physicians take this route. Your existing infrastructure absorbs the new modality.
coordinated care — Clinical and Prescriber Pathway graduates can join the coordinated care clinic network as contracted practitioners. coordinated care Tier 2 registration is a CAD $199 one-time fee.
Continuing education and advanced specialization — substance-specific advanced training (KAT Immersive Experience, MDMA-specific, psilocybin-specific), supervision and mentor pathways, research collaboration with Canadian academic centres.

Frequently asked questions

Can I do two pathways?

Yes. The Foundations course is the shared entry point; you can add advanced modules across pathways. Many physicians complete both Prescriber and a portion of Clinical content; many psychologists complete Clinical and the Integrative module. There is no rule against stacking pathways.

Does my provincial college recognize ATMA CENA's training?

ATMA CENA is a CPA (Canadian Psychological Association) approved CE sponsor (2025). CPA-approved CE counts toward most colleges' continuing competence programs. OPQ recognition is separate; verify directly with your registering college before claiming hours.

How long does each pathway take?

Integrative: 3–6 months part-time. Clinical: 6–12 months part-time. Prescriber: 4–8 months part-time. Most courses are blended (asynchronous online modules + scheduled live sessions). Cohort dates are published on each course page.

Can I start with Foundations before committing to a pathway?

Yes — and many practitioners do. Foundations (CAD $800; 14 CE hours) is the prerequisite for all advanced courses. Take Foundations first, then decide which pathway suits your scope and goals.

What if I am not sure which pathway fits my credential?

Contact an ATMA CENA training advisor via /information-call/ to discuss your credential, province, and practice goals before enrolling.

Can I switch pathways after enrolling?

Yes, with conditions. Foundations transfers across all pathways. Pathway-specific advanced courses (Applied Clinical Practice, Prescribing & Oversight, Advanced Safety & Support) are not interchangeable, but you can add a second pathway's advanced course after completing the first.

Is the Prescriber Pathway only for prescribing?

No. Many psychiatrists and physicians take the Clinical Pathway elements alongside Prescriber to deliver both the prescribing and therapeutic components themselves. The Prescriber Pathway is required if you intend to submit SAP applications or prescribe psychedelics.

What if I am unregulated in my province (e.g., a counsellor in BC, AB, SK, MB, NL)?

Take the Integrative Pathway. Without a regulated provincial credential, you cannot legally serve as therapist of record in a PAP team. The Integrative Pathway gives you foundational literacy and skills for integration support work outside SAP context.

Sources

ATMA CENA — Psychedelic Therapy Training Hub: https://psychedelic.healthcare/psychedelic-therapy-training/
ATMA CENA — Clinical Pathway: https://psychedelic.healthcare/psychedelic-therapy-training/clinical/
ATMA CENA — Prescriber Pathway: https://psychedelic.healthcare/psychedelic-therapy-training/prescriber/
ATMA CENA — Integrative (Essentials) Pathway: https://psychedelic.healthcare/psychedelic-therapy-training/essentials/
ATMA CENA — coordinated care: https://psychedelic.healthcare/find-care
Health Canada SAP Notice — Psychedelic-Assisted Psychotherapy: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/requests-special-access-program-psychedelic-assisted-psychotherapy.html
CAP Practice Guideline — PAP (June 2025): https://www.cap.ab.ca/Portals/0/adam/Content/fQCpza4q7EGXC_psrgnCvA/Link/Psychedelic-Assisted%20Psychotherapy%20-%20June%202025.pdf
Alberta MHSP Regulation 114/2021: https://www.canlii.org/en/ab/laws/regu/alta-reg-114-2021/latest/alta-reg-114-2021.html
Alberta PDTS Licensing: https://www.alberta.ca/psychedelic-drug-treatment-service-provider-licensing
CPSA Ketamine Guidance (March 2026): https://cpsa.ca/wp-content/uploads/2026/03/CPSA_Ketamine-Guidance_March-2026.pdf
CPSA PAPT Facility Accreditation: https://cpsa.ca/facilities-clinics/accreditation/psychedelic-assisted-psychotherapy/
CRPO Psychedelic-Assisted Psychotherapy: https://crpo.ca/resource-articles/psychedelic-assisted-psychotherapy/
BCCSW Practice Guidance — PAP: https://bccsw.ca/for-registrants/standards-scope-of-practice/practice-guidance/practice-guidance-document-for-registrants-psychedelic-assisted-psychotherapy/
BCACC Health Canada Guidelines (October 2024): https://bcacc.ca/wp-content/uploads/2024/10/Health-Canada-Guidelines-on-Psychedelic-Assisted-Therapy-2024.pdf
CPA Approved CE Sponsors: https://cpa.ca/professionaldevelopment/sponsors/
OPQ — Who Practices Psychotherapy: https://www.ordrepsy.qc.ca/web/english/who-practices-psychotherapy
Levin AW, et al. (2024). Therapeutic alliance and psilocybin outcomes. PLoS One. https://pubmed.ncbi.nlm.nih.gov/38483940/
Mitchell JM, et al. (2021). MDMA-assisted therapy Phase 3 (MAPP1). Nat Med. https://pubmed.ncbi.nlm.nih.gov/33972795/
Phelps J (2017). Competencies for psychedelic therapist training. J Humanist Psychol. https://journals.sagepub.com/doi/abs/10.1177/0022167817711304
Brennan W, Belser AB (2022). EMBARK transdiagnostic model. Front Psychol. https://pubmed.ncbi.nlm.nih.gov/35719571/
Swainson J, et al. (2021). CANMAT racemic ketamine recommendations. Can J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/33174760/
Chrenek C, et al. (2024). Edmonton community ketamine program. Front Psychiatry. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1283733/full
Gorman I, et al. (2021). PHRI model. Front Psychol. https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2021.645246/full
Mian MN, et al. (2024). Protective Strategies for Psychedelics Scale. J Psychopharmacol. https://pmc.ncbi.nlm.nih.gov/articles/PMC10851634/
PsyCan SAP Decline (September 2025): https://psychedelicscanada.org/media/2025/09/psycan-discovers-sharp-decline-in-health-canada-approvals-for-doctors-seeking-legal-psychedelic-therapy-for-patients

Which Psychedelic Therapy Training Pathway Is Right for Me?